TRCT
COCP icon

Tower Research Capital (TRC)’s Cocrystal Pharma COCP Stock Holding History

Tower Research Capital (TRC)’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.18K Sell
3,984
-264
-6% -$325 ﹤0.01% 4425
2026
Q1 		$4.29K Sell
4,248
-850
-17% -$877 ﹤0.01% 4211
2025
Q4 		$4.99K Buy
5,098
+1,800
+55% +$1.91K ﹤0.01% 4155
2025
Q3 		$4.12K Sell
3,298
-365
-10% -$563 ﹤0.01% 4398
2025
Q2 		$5.46K Buy
3,663
+1,706
+87% +$2.54K ﹤0.01% 4187
2025
Q1 		$2.78K Buy
1,957
+1,127
+136% +$2.1K ﹤0.01% 4509
2024
Q4 		$1.68K Sell
830
-1,913
-70% -$3.83K ﹤0.01% 4983
2024
Q3 		$4.83K Sell
2,743
-938
-25% -$1.83K ﹤0.01% 4407
2024
Q2 		$8.58K Sell
3,681
-3,775
-51% -$7.36K ﹤0.01% 4332
2024
Q1 		$10.4K Buy
7,456
+1,612
+28% +$2.51K ﹤0.01% 3696
2023
Q4 		$10.1K Buy
5,844
+2,496
+75% +$4.44K ﹤0.01% 4302
2023
Q3 		$6.26K Sell
3,348
-2,265
-40% -$5.68K ﹤0.01% 4627
2023
Q2 		$13.4K Sell
5,613
-3,038
-35% -$7.38K ﹤0.01% 3773
2023
Q1 		$17K Buy
8,651
+3,804
+78% +$8.49K ﹤0.01% 3621
2022
Q4 		$10K Buy
4,847
+2,124
+78% +$5.44K ﹤0.01% 3968
2022
Q3 		$10K Buy
2,723
+577
+27% +$2.7K ﹤0.01% 4517
2022
Q2 		$11K Buy
2,146
+1,445
+206% +$7.7K ﹤0.01% 4361
2022
Q1 		$5K Buy
+701
New +$4.66K ﹤0.01% 5032
2020
Q4 		– Sell
-941
Closed -$11K – 5149
2020
Q3 		$11K Buy
941
+220
+31% +$4.01K ﹤0.01% 4055
2020
Q2 		$13K Buy
+721
New +$8.84K ﹤0.01% 3892
2019
Q3 		– Sell
-8
Closed – – 4135
2019
Q2 		$0 Sell
8
-118
-94% -$3.5K ﹤0.01% 3751
2019
Q1 		$4K Buy
+126
New +$4.61K ﹤0.01% 3143
2018
Q4 		– Sell
-163
Closed -$5K – 3869
2018
Q3 		$5K Buy
+163
New +$7.29K ﹤0.01% 3103

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tower Research Capital (TRC)'s COCP Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Cocrystal Pharma (COCP) stake by 6.2% in Q2 2026, selling an estimated $325 and leaving 3,984 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #4425.

Tower Research Capital (TRC) first reported a position in COCP in Q3 2018 and has held it in 23 quarters since. The position peaked at $17K in Q1 2023. 22 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Tower Research Capital (TRC) held 3,984 shares of Cocrystal Pharma worth $4.18K as of Q2 2026.
  • Tower Research Capital (TRC) sold 264 Cocrystal Pharma shares in Q2 2026, an estimated $325.
  • Cocrystal Pharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4425 holding.
  • Tower Research Capital (TRC) first reported a position in Cocrystal Pharma in Q3 2018 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Cocrystal Pharma position peaked at $17K in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.